132 related articles for article (PubMed ID: 19575577)
21. Secondary neoplasms after stereotactic radiosurgery.
Patel TR; Chiang VL
World Neurosurg; 2014; 81(3-4):594-9. PubMed ID: 24148883
[TBL] [Abstract][Full Text] [Related]
22. Hearing preservation and tumour control after radiosurgery for NF2-related vestibular schwannomas.
Massager N; Delbrouck C; Masudi J; De Smedt F; Devriendt D
B-ENT; 2013; 9(1):29-36. PubMed ID: 23641588
[TBL] [Abstract][Full Text] [Related]
23. Preservation of auditory and vestibular function after surgical removal of bilateral vestibular schwannomas in a patient with neurofibromatosis type 2.
Black FO; Brackmann DE; Hitselberger WE; Purdy J
Am J Otol; 1995 Jul; 16(4):431-43. PubMed ID: 8588642
[TBL] [Abstract][Full Text] [Related]
24. Expression of Ki-67 antigen and vascular endothelial growth factor in sporadic and neurofibromatosis type 2-associated schwannomas.
Saito K; Kato M; Susaki N; Nagatani T; Nagasaka T; Yoshida J
Clin Neuropathol; 2003; 22(1):30-4. PubMed ID: 12617191
[TBL] [Abstract][Full Text] [Related]
25. Multiple schwannomas and meningiomas associated with irradiation in childhood.
Sznajder L; Abrahams C; Parry DM; Gierlowski TC; Shore-Freedman E; Schneider AB
Arch Intern Med; 1996 Sep; 156(16):1873-8. PubMed ID: 8790083
[TBL] [Abstract][Full Text] [Related]
26. Pretreatment growth rate predicts radiation response in vestibular schwannomas.
Niu NN; Niemierko A; Larvie M; Curtin H; Loeffler JS; McKenna MJ; Shih HA
Int J Radiat Oncol Biol Phys; 2014 May; 89(1):113-9. PubMed ID: 24725695
[TBL] [Abstract][Full Text] [Related]
27. [Neurofibromatosis type 2 and auditory brainstem implantation].
Elvsåshagen T; Solyga V; Bakke SJ; Heiberg A; Kerty E
Tidsskr Nor Laegeforen; 2009 Aug; 129(15):1469-73. PubMed ID: 19690597
[TBL] [Abstract][Full Text] [Related]
28. Stereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for tumor control and functional outcomes.
Mallory GW; Pollock BE; Foote RL; Carlson ML; Driscoll CL; Link MJ
Neurosurgery; 2014 Mar; 74(3):292-300; discussion 300-1. PubMed ID: 24335819
[TBL] [Abstract][Full Text] [Related]
29. Predictors of hearing loss after gamma knife radiosurgery for vestibular schwannomas: age, cochlear dose, and tumor coverage.
Brown M; Ruckenstein M; Bigelow D; Judy K; Wilson V; Alonso-Basanta M; Lee JY
Neurosurgery; 2011 Sep; 69(3):605-13; discussion 613-4. PubMed ID: 21471832
[TBL] [Abstract][Full Text] [Related]
30. Glioblastoma multiforme occurring in a patient treated with gamma knife surgery. Case report and review of the literature.
Shamisa A; Bance M; Nag S; Tator C; Wong S; Norén G; Guha A
J Neurosurg; 2001 May; 94(5):816-21. PubMed ID: 11354416
[TBL] [Abstract][Full Text] [Related]
31. Radiation-associated secondary brain tumors after conventional radiotherapy and radiosurgery.
Ecemis GC; Atmaca A; Meydan D
Expert Rev Neurother; 2013 May; 13(5):557-65. PubMed ID: 23621312
[TBL] [Abstract][Full Text] [Related]
32. Radiosurgery for type II neurofibromatosis.
Rowe J; Radatz M; Kemeny A
Prog Neurol Surg; 2008; 21():176-182. PubMed ID: 18810217
[TBL] [Abstract][Full Text] [Related]
33. [A new tumor suppressor gene responsible for type 2 neurofibromatosis is inactivated in neurinoma and meningioma].
Sanson M
Rev Neurol (Paris); 1996 Jan; 152(1):1-10. PubMed ID: 8729390
[TBL] [Abstract][Full Text] [Related]
34. Mouse models of neurofibromatosis 1 and 2.
Gutmann DH; Giovannini M
Neoplasia; 2002; 4(4):279-90. PubMed ID: 12082543
[TBL] [Abstract][Full Text] [Related]
35. Neurofibromatosis type 2 (NF2): diagnosis and management.
Lloyd SK; Evans DG
Handb Clin Neurol; 2013; 115():957-67. PubMed ID: 23931824
[TBL] [Abstract][Full Text] [Related]
36. Multi-session radiosurgery of benign intracranial tumors.
Yeung JT; Karim SA; Chang SD
Neurosurg Clin N Am; 2013 Oct; 24(4):543-51. PubMed ID: 24093572
[TBL] [Abstract][Full Text] [Related]
37. Plasminogen activation in neurofibromatosis 2-associated and sporadic schwannomas.
Sirén V; Antinheimo JP; Jääskeläinen J; Böhling T; Carpén O; Vaheri A
Acta Neurochir (Wien); 2004 Feb; 146(2):111-8. PubMed ID: 14963743
[TBL] [Abstract][Full Text] [Related]
38. Intracranial malignancies occurring more than 20 years after radiation therapy for pituitary adenoma.
Wu-Chen WY; Jacobs DA; Volpe NJ; Dalmau JO; Moster ML
J Neuroophthalmol; 2009 Dec; 29(4):289-95. PubMed ID: 19952902
[TBL] [Abstract][Full Text] [Related]
39. Prolonged propofol infusions in pregnant neurosurgical patients.
Hilton G; Andrzejowski JC
J Neurosurg Anesthesiol; 2007 Jan; 19(1):67-8. PubMed ID: 17198107
[No Abstract] [Full Text] [Related]
40. Proliferative potential of sporadic and neurofibromatosis 2-associated schwannomas as studied by MIB-1 (Ki-67) and PCNA labeling.
Antinheimo J; Haapasalo H; Seppälä M; Sainio M; Carpen O; Jääskeläinen J
J Neuropathol Exp Neurol; 1995 Nov; 54(6):776-82. PubMed ID: 7595650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
